Clinical Trial Update: Changes in Biomarkers Using Prostaglandin Inhibitors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating prostaglandin inhibitors in breast cancer reports biomarker changes; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Hartford Hospital | Conditions: Biomarker Change Linked to Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED